Jin Rong Jie·2025-08-26 08:24Group 1 - The core index of the CSI 1000 Healthcare Index closed at 14247.06 points, with a one-month increase of 7.51%, a three-month increase of 25.91%, and a year-to-date increase of 32.65% [1] - The CSI 1000 Index series selects liquid and representative securities from each industry to form ten industry indices, providing diversified investment targets for investors [1] - The top ten holdings in the CSI 1000 Healthcare Index include: Borui Pharmaceutical (3.76%), Tonghua Golden Horse (2.77%), Zai Jian Pharmaceutical (2.39%), Furuide Co. (1.96%), Zhongsheng Pharmaceutical (1.83%), Rongchang Bio (1.69%), Zhaoyan New Drug (1.69%), Zuoli Pharmaceutical (1.62%), Anke Bio (1.61%), and Yipin Hong (1.46%) [1] Group 2 - The market share of the CSI 1000 Healthcare Index holdings is 54.86% from the Shanghai Stock Exchange and 45.14% from the Shenzhen Stock Exchange [1] - The industry composition of the CSI 1000 Healthcare Index includes: Chemical drugs (34.72%), Medical devices (20.46%), Traditional Chinese medicine (16.77%), Biological drugs (14.77%), Medical commerce and services (7.27%), and Pharmaceutical and biotechnology services (6.01%) [2] - The index sample is adjusted every six months, with adjustments implemented on the next trading day after the second Friday of June and December, and can be adjusted temporarily under special circumstances [2]